LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,521
تعداد دریافت فایل اصل مقاله11,291,330
Mokhtari, Ali Mohammad, Moghadami, Mohsen, Seif, Mozhgan, Mirahmadizadeh, Alireza. (1399). Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran. سامانه مدیریت نشریات علمی, 46(2), 93-102. doi: 10.30476/ijms.2019.83112.1199
Ali Mohammad Mokhtari; Mohsen Moghadami; Mozhgan Seif; Alireza Mirahmadizadeh. "Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran". سامانه مدیریت نشریات علمی, 46, 2, 1399, 93-102. doi: 10.30476/ijms.2019.83112.1199
Mokhtari, Ali Mohammad, Moghadami, Mohsen, Seif, Mozhgan, Mirahmadizadeh, Alireza. (1399). 'Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran', سامانه مدیریت نشریات علمی, 46(2), pp. 93-102. doi: 10.30476/ijms.2019.83112.1199
Mokhtari, Ali Mohammad, Moghadami, Mohsen, Seif, Mozhgan, Mirahmadizadeh, Alireza. Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran. سامانه مدیریت نشریات علمی, 1399; 46(2): 93-102. doi: 10.30476/ijms.2019.83112.1199

Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran

Iranian Journal of Medical Sciences
مقاله 3، دوره 46، شماره 2، خرداد 2021، صفحه 93-102    اصل مقاله (900.56 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2019.83112.1199
نویسندگان
Ali Mohammad Mokhtari1؛ Mohsen Moghadami2؛ Mozhgan Seif3؛ Alireza Mirahmadizadeh* 4
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
4Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: One of the main health problems in the world is hepatitis B virus (HBV) infection. Vaccination and other factors can affect HBV infection. As various effective factors have been reported in different regions and studies, this study aimed to investigate the association between HBV infection and routine vaccination and other effective factors 25 years since the launch of the national vaccination program in Iran.
Methods: This cross-sectional study, conducted in 2017 in Shiraz (Iran), investigated factors such as demographic variables such as gender, education, and occupation, vaccination status, and the potential risk factors for HBV infection. Hepatitis B surface antigen (HBsAg) and anti-hepatitis B core antibody (HBc Ab) tests were performed to determine HBV infection status. The data were analyzed using R software (version 3.5.2), using multivariate logistic regressions and machine learning methods. The level of significance was considered below 0.05.
Results: A total of 2720 individuals were enrolled in the study (194 cases with HBV infection). Based on the logistic regression analyses, factors such as a family history of the disease (OR=2.53, p <0.001), vaccination (OR=0.57, P=0.004), a history of high-risk behaviors (OR=1.48, P=0.022), and occupation (OR=1.80, P=0.035) were significantly associated with HBV infection. Based on the conditional tree method, a family history of infection (p <0.001) and vaccination (P=0.023) were two important factors in classifying individuals for HBV infection.
Conclusion: Based on the different methods applied in this study, HBV infection was affected by factors such as a family history of the disease, national HBV vaccination, and occupation. It appears that HBV vaccination, launched by the Iranian Ministry of Health and Medical Education in 1993, has reduced HBV infection.
کلیدواژه‌ها
Hepatitis B؛ Risk factors؛ Vaccination؛ Logistic models؛ Machine learning
سایر فایل های مرتبط با مقاله
مراجع
  1. Marlen Ivon CF, Zaily DG, Conde-Eduardo Leda Patricia DS, Enrique GG, Enrique AS, Yadina MP. Current Condition of Chronic Hepatitis B Virus Infection in Cuban Adults. Curr Ther Res Clin Exp. 2017;85:15-9. doi: 10.1016/j.curtheres.2017.04.007. PubMed PMID: 29158854; PubMed Central PMCID: PMCPMC5681292.
  2. Ben Hadj M, Bouguerra H, Saffar F, Chelly S, Hechaichi A, Talmoudi K, et al. Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia. Vaccine. 2018;36:5858-64. doi: 10.1016/j.vaccine.2018.08.038. PubMed PMID: 30145100.
  3. Hassanipour S, Mohammadzadeh M, Mansour-Ghanaei F, Fathalipour M, Joukar F, Salehiniya H, et al. The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis. J Gastrointest Cancer. 2019;50:193-200. doi: 10.1007/s12029-019-00207-y. PubMed PMID: 30725358.
  4. Ocama P, Opio CK, Lee WM. Hepatitis B virus infection: current status. Am J Med. 2005;118:1413. doi: 10.1016/j.amjmed.2005.06.021. PubMed PMID: 16378788.
  5. Kargar Kheirabad A, Elmira Jokari E, Sajjadi MJ, Gouklani H. Prevalence of Hepatitis B virus between Qeshm Island people in 2013-2014, Iran. J Med Life. 2015;8:173-7. PubMed PMID: 28316686; PubMed Central PMCID: PMCPMC5348928.
  6. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18 Suppl 1:S20-2. doi: 10.1016/s0264-410x(99)00456-9. PubMed PMID: 10683538.
  7. Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, et al. Reprint of: Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005. Vaccine. 2013;31:J56-61. doi: 10.1016/j.vaccine.2013.08.013. PubMed PMID: 23948228.
  8. Gabbuti A, Romano L, Blanc P, Meacci F, Amendola A, Mele A, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129-32. doi: 10.1016/j.vaccine.2007.01.045. PubMed PMID: 17291637.
  9. Amin S, Andalibi S, Mahmoudi M. Anti-HBs response and its protective effect in children and adults receiving hepatitis B recombinant vaccine in Tehran. Iran J Med Sci. 2002;27:101-5.
  10. Jouneghani AS, Chaleshtori MH, Khoshdel A, Kheiri S, Farrokhi E, Khalafian P, et al. Evaluation of response to hepatitis B vaccine in Iranian 6-18-year-old students. J Res Med Sci. 2017;22:116. doi: 10.4103/jrms.JRMS_204_17. PubMed PMID: 29184574; PubMed Central PMCID: PMCPMC5680656.
  11. Ardakani AT, Soltani B, Sharif M, Moosavi GA, Khademian M. Evaluation of serum hepatitis B antibody level in vaccinated children after 14 years in Kashan, Iran. Journal of Gorgan University of Medical Sciences. 2012;14:104-8. Persian.
  12. Costa CI, Delgado IF, da Costa JA, de Carvalho RF, Mouta Sda S, Jr., Vianna CO, et al. Establishment and validation of an ELISA for the quantitation of HBsAg in recombinant hepatitis B vaccines. J Virol Methods. 2011;172:32-7. doi: 10.1016/j.jviromet.2010.12.010. PubMed PMID: 21185330.
  13. Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol. 2017;31:239-47. doi: 10.1016/j.bpg.2017.05.008. PubMed PMID: 28774405.
  14. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis. 2002;185:713-9. doi: 10.1086/339192. PubMed PMID: 11920288.
  15. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13:9-19. doi: 10.1016/j.ijid.2008.06.019. PubMed PMID: 18835208; PubMed Central PMCID: PMCPMC2651958.
  16. Morisco F, Stroffolini T, Lombardo FL, Guarino M, Camera S, Cossiga V, et al. Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination. Dig Liver Dis. 2017;49:1257-61. doi: 10.1016/j.dld.2017.06.002. PubMed PMID: 28676420.
  17. Shafiq M, Nadeem M, Sattar Z, Khan SM, Faheem SM, Ahsan I, et al. Identification of risk factors for hepatitis B and C in Peshawar, Pakistan. HIV AIDS (Auckl). 2015;7:223-31. doi: 10.2147/HIV.S67429. PubMed PMID: 26316823; PubMed Central PMCID: PMCPMC4544815.
  18. Chen Y, Luo Y, Huang W, Hu D, Zheng RQ, Cong SZ, et al. Machine-learning-based classification of real-time tissue elastography for hepatic fibrosis in patients with chronic hepatitis B. Comput Biol Med. 2017;89:18-23. doi: 10.1016/j.compbiomed.2017.07.012. PubMed PMID: 28779596.
  19. Khan S, Ullah R, Khan A, Ashraf R, Ali H, Bilal M, et al. Analysis of hepatitis B virus infection in blood sera using Raman spectroscopy and machine learning. Photodiagnosis Photodyn Ther. 2018;23:89-93. doi: 10.1016/j.pdpdt.2018.05.010. PubMed PMID: 29787817.
  20. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003;9:416-23. doi: 10.1038/nm843. PubMed PMID: 12640447.
  21. Ross EG, Shah NH, Dalman RL, Nead KT, Cooke JP, Leeper NJ. The use of machine learning for the identification of peripheral artery disease and future mortality risk. J Vasc Surg. 2016;64:1515-22 e3. doi: 10.1016/j.jvs.2016.04.026. PubMed PMID: 27266594; PubMed Central PMCID: PMCPMC5079774.
  22. Garcia D, Porras A, Rico Mendoza A, Alvis N, Navas MC, De La Hoz F, et al. Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence. Vaccine. 2018;36:2721-6. doi: 10.1016/j.vaccine.2017.11.004. PubMed PMID: 29609968.
  23. Mirahmadizadeh A, Zahmatkesh S, Kashfi nezhad MS, Sayadi M, Tabatabaee HR, Mokhtari AM. Vaccination Coverage in Children of Fars Province, 2017: Achievement of Global Vaccine Action Plan Goals. Sadra Medical Sciences Journal. 2018;6:251-60. Persian.
  24. Centers for Disease Control and Prevention. CDC Recommendation for Hepatitis B Vaccination Among Adults With Diabetes: Grading of Scientific Evidence in Support of Key Recommendations. [cited 13 June 2014]. Available from: http://www.cdc.gov/vaccines/acip/recs/grade/hepb-vac-adults-diabetes.html
  25. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med. 1990;9:1447-54. doi: 10.1002/sim.4780091208. PubMed PMID: 2281232.
  26. Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program. BMC Infect Dis. 2014;14:7. doi: 10.1186/1471-2334-14-7. PubMed PMID: 24397793; PubMed Central PMCID: PMCPMC3898092.
  27. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053-63. doi: 10.1016/S0140-6736(14)60220-8. PubMed PMID: 24954675.
  28. Han H, Guo X, Yu H, editors. Variable selection using mean decrease accuracy and mean decrease gini based on random forest. 26-28 Aug 2016. Beijing: 7th IEEE international conference on software engineering and service science (ICSESS); 2016. doi: 10.1109/ICSESS.2016.7883053.
  29. Menke A, Arloth J, Putz B, Weber P, Klengel T, Mehta D, et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology. 2012;37:1455-64. doi: 10.1038/npp.2011.331. PubMed PMID: 22237309; PubMed Central PMCID: PMCPMC3327850.
  30. Pugach O, Cannon DS, Weiss RB, Hedeker D, Mermelstein RJ. Classification Tree Analysis as a Method for Uncovering Relations Between CHRNA5A3B4 and CHRNB3A6 in Predicting Smoking Progression in Adolescent Smokers. Nicotine Tob Res. 2017;19:410-6. doi: 10.1093/ntr/ntw197. PubMed PMID: 27613882; PubMed Central PMCID: PMCPMC5896442.
  31. Strobl C, Boulesteix A-L, Augustin T. Unbiased split selection for classification trees based on the Gini index. Computational Statistics & Data Analysis. 2007;52:483-501. doi: 10.1016/j.csda.2006.12.030.
  32. Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, et al. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol. 2018;136:565-76. doi: 10.1007/s11060-017-2685-4. PubMed PMID: 29159777.
  33. Strobl C, Boulesteix AL, Zeileis A, Hothorn T. Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics. 2007;8:25. doi: 10.1186/1471-2105-8-25. PubMed PMID: 17254353; PubMed Central PMCID: PMCPMC1796903.
  34. Kumar R, Indrayan A. Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr. 2011;48:277-87. doi: 10.1007/s13312-011-0055-4. PubMed PMID: 21532099.
  35. Pereira V, Wolf JM, Luz C, Stumm GZ, Boeira TDR, Galvan J, et al. Risk factors for hepatitis B transmission in South Brazil. Mem Inst Oswaldo Cruz. 2017;112:544-50. doi: 10.1590/0074-02760170043. PubMed PMID: 28767979; PubMed Central PMCID: PMCPMC5530546.
  36. Shedain PR, Devkota MD, Banjara MR, Ling H, Dhital S. Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal. BMC Infect Dis. 2017;17:667. doi: 10.1186/s12879-017-2763-4. PubMed PMID: 29017456; PubMed Central PMCID: PMCPMC5633872.
  37. Ximenes RAA, Figueiredo GM, Cardoso MRA, Stein AT, Moreira RC, Coral G, et al. Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination. Am J Trop Med Hyg. 2015;93:1341-8. doi: 10.4269/ajtmh.15-0216. PubMed PMID: 26503280; PubMed Central PMCID: PMCPMC4674256.
  38. de la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008;12:183-9. doi: 10.1016/j.ijid.2007.06.010. PubMed PMID: 17913535.
  39. Makuza JD, Rwema JOT, Ntihabose CK, Dushimiyimana D, Umutesi J, Nisingizwe MP, et al. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infect Dis. 2019;19:381. doi: 10.1186/s12879-019-4013-4. PubMed PMID: 31053097; PubMed Central PMCID: PMCPMC6499977.
آمار
تعداد مشاهده مقاله: 4,822
تعداد دریافت فایل اصل مقاله: 2,898


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب